Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 157 | 0 | 1,479 | 40,792 | 9,038 |
Gross Profit | 157 | N/A | 1,479 | 40,792 | 9,038 |
Operating Expenses | 35,659 | 33,792 | 33,245 | 33,774 | 37,915 |
Operating Income | -35,502 | -33,792 | -31,766 | 7,018 | -28,877 |
Other Income | -5,520 | 6,382 | -3,932 | -1,643 | -14,866 |
Pre-tax Income | -41,022 | -27,410 | -35,698 | 5,375 | -43,743 |
Income Tax | 65 | 2 | 135 | 133 | 102 |
Net Income Continuous | -41,087 | -27,412 | -35,833 | 5,242 | -43,845 |
Net Income | $-41,087 | $-27,412 | $-35,833 | $5,242 | $-43,845 |
EPS Basic Total Ops | -0.42 | -0.24 | -0.30 | 0.06 | -0.48 |
EPS Basic Continuous Ops | -0.39 | -0.26 | -0.34 | 0.05 | -0.47 |
EPS Diluted Total Ops | -0.42 | -0.24 | -0.30 | 0.06 | -0.48 |
EPS Diluted Continuous Ops | -0.39 | -0.26 | -0.34 | 0.05 | -0.47 |
EBITDA(a) | $-33,522 | $-31,797 | $-29,668 | $8,927 | $-26,957 |